The hospital independently developed an innovative blue laser surgical device, pioneering a new “day surgery” model for benign prostatic hyperplasia (BPH). This has opened up a new surgical pathway for elderly and high-risk patients. The surgery is highly safe, providing excellent clinical outcomes. The 200W blue laser system has been used in over 15,000 clinical applications across Taiwan, China, Indonesia, Brazil, Belarus, and European countries, covering 600+ hospitals in China and globally.
Advantages & Clinical Features
High Vaporization Efficiency
450nm blue laser is strongly absorbed by hemoglobin, offering 2-3 times higher vaporization speed than other lasers. BPH size 30-80g only requires 10-30 minutes.
Excellent Function Preservation
Retrograde ejaculation rate reduced to below 6% (vs. >60% with TURP). IIEF scores remain stable or slightly improved. Sexual function well preserved.
Minimal Bleeding & High Safety
Coagulation depth ~0.2mm, low transfusion rate (<1%). Suitable for patients on anticoagulants. Short learning curve: only 9-11 cases to achieve mature technique.
Day Surgery Model
Short hospital stay, minimal trauma, fast recovery. Accessible as day surgery for appropriate candidates.
Clinical Outcomes & Achievements
15,000+ Global Cases
Used in 30,000+ procedures across 600+ hospitals in China and worldwide for BPH treatment.
Extended Applications
Also applicable for bladder tumors, gynecological lesions, and stomatological conditions with precise vaporization and minimal thermal damage.
Proven Safety Profile
Extensive clinical data demonstrates consistent safety across diverse patient populations including elderly and high-risk individuals.
Contact & Referrals
For international patient referrals, please contact our International Office:
Email: ieoffice@xjtufh.edu.cn | Tel: +86-(029)85324199
Contacts: Ms. Fang / Ms. Li